Barbara Ryan's Insider Trades & SAST Disclosures
Barbara Ryan's most recent trade in MiNK Therapeutics Inc was a trade of 2,019 Common Stock done at an average price of $8.8 . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barbara Ryan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 8.79 per share. | 03 Mar 2025 | 2,019 | 17,048 | - | 8.8 | 17,747 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 01 Dec 2024 | 24,229 | 150,336 | - | 0.7 | 17,687 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.82 per share. | 03 Sep 2024 | 21,649 | 126,107 | - | 0.8 | 17,752 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 17,841 | 104,458 | - | 1.0 | 17,663 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 01 Mar 2024 | 18,685 | 86,617 | - | 1.0 | 17,751 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 01 Dec 2023 | 17,068 | 67,932 | - | 1.0 | 17,751 | Common Stock |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 2.09 per share. | 01 Mar 2023 | 8,493 | 28,844 | - | 2.1 | 17,750 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 01 Dec 2022 | 6,801 | 20,351 | - | 2.6 | 17,751 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 15 Sep 2022 | 13,550 | 13,550 | - | 2.6 | 35,501 | Common Stock |
| MiNK Therapeutics Inc | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,435 | 10,435 | - | - | Stock Option | |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 8,588 | 21,053 | - | 0 | Common Stock | |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,317 | 2,317 | - | 0 | Common Stock | |
| NAYA Biosciences | Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,317 | 2,317 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges